The biotech industry may be cooling off, but there’s still plenty to be excited about when it comes to the underlying ...

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...

On March 17, analyst Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Cytokinetics, Incorporated (NASDAQ:CYTK ...

NEW YORK (Reuters) -Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

Holding Bitcoin could help biotech firms survive the long period of time it takes to bring products to market, says Atai Life ...

Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock ...

CINCINNATI ( Cincinnati Business Courier) - A growing biotech and pharmaceuticals manufacturer that announced a large ...

Learn how AI-driven TechBio is revolutionizing biotech in our exclusive interview with Bullfrog AI CEO Vin Singh.

Lower rates make more funding available, which helps biotech companies expand, draw in venture capital, and expedite drug development, according to Genetic Engineering and Biotechnology News.

Lower rates make more funding available, which helps biotech companies expand, draw in venture capital, and expedite drug development, according to Genetic Engineering and Biotechnology News.

At this year’s ABRF Annual Meeting (23–26 March; NV, USA), biotech companies had the opportunity to showcase their technology ...